BridgeBio has demonstrably advanced this development of an novel therapy for amyloid heart disease, leveraging the compound. Initial clinical data indicates promising outcomes for individuals affected from this https://bridgebio527242.sharebyblog.com/42008242/bridgebio-progresses-cardiac-amyloidosis-treatment-using-the-therapy